EUVIMEDObjevte EUVIMED
ÜbersichtsarbeitOpen access

Ferrocenyl ferroptosis inducers as an emerging class of anticancer agents: a mini review

Mateusz Klarek iD, Aryan Gautam iD, Konrad Kowalski iD

RSC Medicinal Chemistry · 2026 · 17 (3) · 1252-1270

DOI: 10.1039/d5md00935a ↗

At a glance

Übersichtsarbeit in RSC Medicinal Chemistry, 2026. Written by Mateusz Klarek and 2 co-authors. Institution: Department of Organic Chemistry, Faculty of Chemistry, University of Łódź Tamka 12 91-403 Łódź Poland kondor15@wp.pl konrad.kowalski@chemia.uni.lodz.…. Cited 5 times so far (Crossref); 142 references. The full text is freely available in PubMed Central. Funded by: Uniwersytet Łódzki.

AbstraktBibliografické údajeCiteRelated studies

Abstract (original language)

Ferroptosis is one of the regulated cell death pathways. Molecular mechanisms underlying ferroptosis involve iron-dependent lipid peroxidation, which results in cell-deleterious membrane damage.

Authors and institutions

  • Department of Organic Chemistry, Faculty of Chemistry, University of Łódź Tamka 12 91-403 Łódź Poland kondor15@wp.pl konrad.kowalski@chemia.uni.lodz.pl.

ORCID profiles: Mateusz Klarek, Aryan Gautam, Konrad Kowalski

Funding

  • Uniwersytet Łódzki

Cite

APA

Klarek, M., Gautam, A., & Kowalski, K. (2026). Ferrocenyl ferroptosis inducers as an emerging class of anticancer agents: a mini review. RSC Medicinal Chemistry, 17(3), 1252-1270. https://doi.org/10.1039/d5md00935a

Vancouver

Klarek M, Gautam A, Kowalski K. Ferrocenyl ferroptosis inducers as an emerging class of anticancer agents: a mini review. RSC Medicinal Chemistry. 2026;17(3):1252-1270. doi:10.1039/d5md00935a

BibTeX
@article{Klarek2026,
  author = {Klarek, Mateusz and Gautam, Aryan and Kowalski, Konrad},
  title = {Ferrocenyl ferroptosis inducers as an emerging class of anticancer agents: a mini review},
  journal = {RSC Medicinal Chemistry},
  year = {2026},
  volume = {17},
  number = {3},
  pages = {1252--1270},
  doi = {10.1039/d5md00935a}
}
Start for free →